FDA’s Third-Party Inspection Program Faces Internal, External Hurdles
This article was originally published in The Gray Sheet
Executive Summary
FDA's decision to generally wait until all participating auditors from the 14 AP firms perform their first training audit before scheduling their second appears to be hindering the agency's third-party inspection initiative